Microbial metabolite sensor GPR43 controls severity of experimental GVHD
The microbial metabolite sensor GPR43 has been previously shown to be a crucial modulator of immune responses. Here the authors show GPR43 is required for controlling disease pathology severity in the context of experimental models of GVHD.
Guardado en:
Autores principales: | Hideaki Fujiwara, Melissa D. Docampo, Mary Riwes, Daniel Peltier, Tomomi Toubai, Israel Henig, S. Julia Wu, Stephanie Kim, Austin Taylor, Stuart Brabbs, Chen Liu, Cynthia Zajac, Katherine Oravecz-Wilson, Yaping Sun, Gabriel Núñez, John E. Levine, Marcel R.M. van den Brink, James L. M. Ferrara, Pavan Reddy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c3db952590146dbaba8c347ece59caa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
GVHD TREATMENT
por: Elif BirtaşAteşoğlu
Publicado: (2021) -
Acetate sensing by GPR43 alarms neutrophils and protects from severe sepsis
por: Katja Schlatterer, et al.
Publicado: (2021) -
Bornlisy Attenuates Colitis-Associated Colorectal Cancer via Inhibiting GPR43-Mediated Glycolysis
por: Xia Lu, et al.
Publicado: (2021) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
por: Kudakwashe Mhandire, et al.
Publicado: (2021) -
Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response
por: Krist Helen Antunes, et al.
Publicado: (2019)